![](/img/cover-not-exists.png)
494 USE OF OMALIZUMAB FOR CESSATION OF CORTICOSTEROID THERAPY IN A PATIENT WITH PULMONARY SARCOIDOSIS, ASPERGILLOMAS, LONG-STANDING ASTHMA, AND ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS.
Wray, C. J., Stenbit, A. E.Volume:
54
Language:
english
Journal:
Journal of Investigative Medicine
DOI:
10.2310/6650.2005.X0004.493
Date:
January, 2006
File:
PDF, 358 KB
english, 2006